Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Tempus AI

Market Cap: US$10.0b

Operates as a healthcare technology company in the United States.

AstraZeneca

Market Cap: UK£183.7b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Natera

Market Cap: US$45.1b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €199.0m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Xeris Biopharma Holdings

Market Cap: US$1.5b

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

AbbVie

Market Cap: US$441.9b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Pangaea Oncology

Market Cap: €55.7m

A precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

CanSino Biologics

Market Cap: HK$10.6b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Renata

Market Cap: ৳54.3b

Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh and Portugal.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$126.3b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

Mesoblast

Market Cap: AU$3.1b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

CSPC Innovation Pharmaceutical

Market Cap: CN¥59.5b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

Akeso

Market Cap: HK$94.0b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Teva Pharmaceutical Industries

Market Cap: US$42.5b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.8b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Innovent Biologics

Market Cap: HK$166.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Galderma Group

Market Cap: CHF 41.0b

Operates as a dermatology company worldwide.

InSilico Medicine Cayman TopCo

Market Cap: HK$26.3b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

Aroa Biosurgery

Market Cap: AU$202.4m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Sotera Health

Market Cap: US$5.5b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥11.8t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Merck

Market Cap: US$321.8b

Operates as a healthcare company worldwide.

hVIVO

Market Cap: UK£47.4m

Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.

BioGaia

Market Cap: SEK 11.4b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Ligand Pharmaceuticals

Market Cap: US$5.9b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Selvita

Market Cap: zł523.1m

Provides drug discovery, drug development, and contract testing services in Poland.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$60.0b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

ALK-Abelló

Market Cap: DKK 49.1b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

Strides Pharma Science

Market Cap: ₹91.6b

A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.

WuXi XDC Cayman

Market Cap: HK$80.9b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Viyash Scientific

Market Cap: ₹114.8b

Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.

Tecan Group

Market Cap: CHF 2.2b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.